Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Proteinuria

bosentan anhydrous has been researched along with Proteinuria in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wimmersberger, Y; Zuercher, D1
Ikebe, M; Nakayama, Y; Nonoguchi, H; Shimada, K; Tanzawa, K; Tashima, Y; Tomita, K1
Bäcker, A; Bader, M; Cervenka, L; Dvorák, P; Ganten, D; Janda, J; Kopkan, L; Kramer, HJ; Malý, J; Opocenský, M; Tesar, V; Vanecková, I; Vernerová, Z1
Bäcker, A; Cervenka, L; Kramer, HJ; Opocensky, M; Vanêcková, I; Vernerová, Z1
Bäcker, A; Cervenka, L; Dvorák, P; Eis, V; Kramer, HJ; Opocenský, M; Schejbalová, S; Vanecková, I; Vernerová, Z1
Egido, J; Gómez-Garre, D; Gutierrez, S; Largo, R; Liu, XH; López-Armada, MJ; Palacios, I1
Bruneval, P; Clozel, JP; Clozel, M; Heudes, D; Osterwalder, R; Qiu, C; Roeckel, A1
Bernal, R; Blanco, J; Egido, J; Gomez-Garre, D; Gomez-Guerrero, C; Lopez-Franco, O; Ortega, L; Sugaya, T; Suzuki, Y; Tejera, N1

Other Studies

8 other study(ies) available for bosentan anhydrous and Proteinuria

ArticleYear
Graves' disease associated with primary systemic sclerosis.
    Orbit (Amsterdam, Netherlands), 2009, Volume: 28, Issue:4

    Topics: Azathioprine; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Graves Disease; Humans; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Proteinuria; Raynaud Disease; Scleroderma, Systemic; Sulfonamides

2009
Regulation of endothelin-converting enzyme 1 in nephrotic syndrome in rats.
    Nephron. Experimental nephrology, 2003, Volume: 94, Issue:4

    Topics: Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Bosentan; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelin-Converting Enzymes; Enzyme Induction; Gene Expression Regulation, Enzymologic; Kidney Glomerulus; Male; Metalloendopeptidases; Nephrons; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Time Factors

2003
Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Kidney & blood pressure research, 2004, Volume: 27, Issue:4

    Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Creatinine; Electrolytes; Endothelin Receptor Antagonists; Endothelin-1; Homozygote; Hypertension, Renal; Kidney; Male; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Renin; Sodium, Dietary; Sulfonamides

2004
Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:4

    Topics: Animals; Animals, Genetically Modified; Atrasentan; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Endothelin A Receptor Antagonists; Endothelin-1; Glomerulosclerosis, Focal Segmental; Heart Ventricles; Hypertension; Kidney; Male; Myocardium; Organ Size; Osmolar Concentration; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride, Dietary; Sulfonamides; Survival Analysis

2005
Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats.
    Vascular pharmacology, 2006, Volume: 45, Issue:3

    Topics: Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrasentan; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Glomerulosclerosis, Focal Segmental; Heterozygote; Hypertension; Male; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Renin; Sodium Chloride, Dietary; Sulfonamides; Time Factors

2006
An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis.
    Kidney international, 1996, Volume: 50, Issue:3

    Topics: Animals; Antibody Specificity; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; In Situ Hybridization; Kidney; Kidney Function Tests; Protein Precursors; Proteinuria; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Sulfonamides

1996
Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bosentan; Cilazapril; Endothelin Receptor Antagonists; Kidney; Kidney Function Tests; Male; Organ Size; Proteinuria; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Sulfonamides

1999
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1.
    The American journal of pathology, 2001, Volume: 159, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bosentan; Endothelins; Extracellular Matrix; Isoquinolines; Kidney; Kidney Diseases; Kidney Tubules; Kinetics; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Proteinuria; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; RNA, Messenger; Serum Albumin, Bovine; Sulfonamides; Tetrahydroisoquinolines; Transcription Factor AP-1; Transforming Growth Factor beta

2001